Porto Alegre, RIO%20GRANDE%20DO%20SUL3 Active Studies

Esophageal Cancer Clinical Trials in Porto Alegre, RIO%20GRANDE%20DO%20SUL

Find 3 actively recruiting esophageal cancer clinical trials in Porto Alegre, RIO%20GRANDE%20DO%20SUL. Connect with local research sites and explore new treatment options.

3
Active Trials
1
Sponsors
450
Enrolling

Recruiting Esophageal Cancer Studies in Porto Alegre

RecruitingPorto Alegre, RIO%20GRANDE%20DO%20SULNCT05319730

A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)

This is a Phase 1/2, multicenter, randomized, open-label umbrella platform study to evaluate the safety and efficacy of investigational agents with or without pembrolizumab and/or chemotherapy, for th...

230 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingPorto Alegre, RIO%20GRANDE%20DO%20SULNCT06469944

Substudy 06C: A Study of Sacituzumab Tirumotecan (MK-2870) With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

This is a phase 1/2, multicenter, open-label umbrella platform study that will evaluate the safety and tolerability of sacituzumab tirumotecan with pembrolizumab and fluoropyrimidine chemotherapy for ...

130 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingPorto Alegre, RIO%20GRANDE%20DO%20SULNCT06445972

Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)

This is a phase 1/2 multicenter, open-label umbrella platform study that will evaluate the safety and efficacy of sacituzumab tirumotecan (MK-2870) plus paclitaxel versus ramucirumab plus paclitaxel, ...

90 participants
Merck Sharp & Dohme LLC
View Study Details

About Esophageal Cancer Clinical Trials in Porto Alegre

Esophageal cancer occurs in the esophagus, the tube connecting the throat to the stomach. The two main types are squamous cell carcinoma and adenocarcinoma. Treatment may include surgery, chemotherapy, radiation, and immunotherapy.

There are currently 3 esophageal cancer clinical trials recruiting participants in Porto Alegre, RIO%20GRANDE%20DO%20SUL. These studies are seeking a combined 450 participants. Research is being sponsored by Merck Sharp & Dohme LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.

Esophageal Cancer Clinical Trials in Porto Alegre — FAQ

Are there esophageal cancer clinical trials in Porto Alegre?

Yes, there are 3 esophageal cancer clinical trials currently recruiting in Porto Alegre, RIO%20GRANDE%20DO%20SUL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Porto Alegre?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Porto Alegre research site will contact you about next steps.

Are clinical trials in Porto Alegre free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Porto Alegre studies also compensate for your time and travel.

What esophageal cancer treatments are being tested?

The 3 active trials in Porto Alegre are testing new therapies including novel drugs, biologics, and treatment approaches for esophageal cancer.

Data updated March 2, 2026 from ClinicalTrials.gov